re: Ann: Notice of Annual General Meeting/Pro... Hey Crisis, good work as usual.
Perhaps you could raise the question of funding and whether we're still looking at a 60/40 debt:equity ratio. According to the May 18 Debt Funding Update...
Potential debt funders were asked to submit expressions of interest and indicative term sheets, and submissions have been received which more than cover the company’s anticipated debt requirements.
Perhaps RES will consider an increase to the debt funding portion so as to not overly dilute shareholders. I know debt funding has its own implications what with interest repayments and all, however I'd much prefer a 70:30 split.
- Forums
- ASX - By Stock
- RES
- Ann: Notice of Annual General Meeting/Proxy Form
Ann: Notice of Annual General Meeting/Proxy Form , page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RES (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online